Astrana Health (NASDAQ:ASTH – Get Free Report) is one of 64 public companies in the “Management consulting services” industry, but how does it contrast to its peers? We will compare Astrana Health to similar companies based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, risk, valuation and earnings.
Profitability
This table compares Astrana Health and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Astrana Health | 4.49% | 11.52% | 6.67% |
Astrana Health Competitors | -36.67% | -366.50% | -18.15% |
Analyst Ratings
This is a summary of recent recommendations and price targets for Astrana Health and its peers, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Astrana Health | 0 | 1 | 1 | 0 | 2.50 |
Astrana Health Competitors | 67 | 526 | 1383 | 58 | 2.70 |
Valuation & Earnings
This table compares Astrana Health and its peers top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Astrana Health | $1.39 billion | $60.72 million | 30.28 |
Astrana Health Competitors | $1.72 billion | $122.66 million | 11.49 |
Astrana Health’s peers have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Institutional & Insider Ownership
35.9% of Astrana Health shares are owned by institutional investors. Comparatively, 39.0% of shares of all “Management consulting services” companies are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Comparatively, 29.4% of shares of all “Management consulting services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Volatility & Risk
Astrana Health has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Astrana Health’s peers have a beta of 0.79, suggesting that their average stock price is 21% less volatile than the S&P 500.
Summary
Astrana Health peers beat Astrana Health on 8 of the 13 factors compared.
Astrana Health Company Profile
Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA.
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.